Meeting the challenge of engaging men in HIV prevention and treatment

Meeting the challenge of engaging men in HIV prevention and treatment
Navy Petty Officer 1st Class Oliver Arceo draws blood from a sailor for routine HIV testing. Credit: US Navy photo by Petty Officer 1st Class Marie Montez

A new commentary from National Institutes of Health scientists asserts that engaging men in HIV prevention and care is essential to the goal of ending the HIV pandemic. The article by Adeola Adeyeye, M.D., M.P.A., and David Burns, M.D., M.P.H., of the National Institute of Allergy and Infectious Diseases (NIAID) and Michael Stirratt, Ph.D., of the National Institute of Mental Health (NIMH) also discusses potential solutions.

Scientific research has proven that people with HIV who take (ART) as prescribed and achieve and maintain an undetectable level of virus in the blood have effectively no risk of transmitting the virus to their HIV-uninfected sexual partners. Other research has shown that when HIV-uninfected people consistently take a single daily oral tablet of the antiretroviral drugs emtricitabine/tenofovir disoproxil fumarate, their risk of acquiring HIV infection is reduced by as much as 95 percent. The challenge is implementing these approaches, known as treatment as prevention and pre-exposure prophylaxis (PrEP), and other forms of HIV prevention in a timely manner among everyone who needs them.

The authors point out that in sub-Saharan Africa, men are less likely than women to know their HIV status, engage in HIV care in a timely manner, stay in care and maintain an undetectable level of virus in the blood. The authors also note that in the United States, disparities by age, race and ethnicity persist in the use of ART among men who have sex with men

New strategies to engage men in HIV prevention and treatment must address three critical issues, the authors write. These are the lack of "touch points" where men naturally interact with the health care system; gender norms and prevailing constructs of masculinity, which typically subordinate health care to other concerns; and HIV stigma and discrimination. The authors describe innovative approaches being explored to overcome these challenges, including establishing HIV testing and care in workplaces and sports programs, ART home delivery, HIV self-testing, and the MenStar Coalition created by the President's Emergency Plan for AIDS Relief (PEPFAR), Unitaid, the Elton John AIDS Foundation and others to expand HIV diagnosis and treatment for men.


Explore further

15 years later, PEPFAR continues to save lives

More information: A Adeyeye et al. Engaging men in HIV treatment and prevention. The Lancet (2018). DOI: 10.1016/S0140-6736(18)32994-5
Journal information: The Lancet

Citation: Meeting the challenge of engaging men in HIV prevention and treatment (2018, November 29) retrieved 11 December 2019 from https://medicalxpress.com/news/2018-11-engaging-men-hiv-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments